Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Saura, PA"'
Autor:
López-Herradón A, Piñera AR, Tomé F, Rodríguez-Arguisjuela MG, Saura PA, Saura J, Pérez-Higueras A, Mahíllo I, De la Piedra C, Álvarez-Galovich L
Publikováno v:
Revista de Osteoporosis y Metabolismo Mineral, Vol 11, Iss 4, Pp 92-97 (2020)
Objetivo: Actualmente, existen pocos datos sobre la influencia a largo plazo del polimetilmetacrilato (PMMA) en la integridad de los cuerpos vertebrales tras la vertebroplastia percutánea (VP). Resulta de interés investigar la posible relación ent
Externí odkaz:
https://doaj.org/article/56f63880b6304c4087f9154a635e13b7
Autor:
López-Herradón, A, Piñera, AR, Tomé, F, Rodríguez-Arguisjuela, MG, Saura, PA, Saura, J, Pérez-Higueras, A, Mahíllo, I, Piedra, C De la, Álvarez-Galovich, L
Publikováno v:
Revista de Osteoporosis y Metabolismo Mineral, Volume: 11, Issue: 4, Pages: 92-97, Published: 06 APR 2020
Resumen Objetivo: Actualmente, existen pocos datos sobre la influencia a largo plazo del polimetilmetacrilato (PMMA) en la integridad de los cuerpos vertebrales tras la vertebroplastia percutánea (VP). Resulta de interés investigar la posible relac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______624::c8759fc5bc5ee1f314cb08f476ba7b6b
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2019000400003&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2019000400003&lng=en&tlng=en
Autor:
Soriano-García JL, López-Díaz A, Solares-Asteasuainzarra M, Baladrón-Castrillo I, Batista-Albuerne N, García-García I, González-Méndez L, Perera-Negrín Y, Valenzuela-Silva CM, Pedro AP, Quevedo-Sotolongo LS, Hernández-González I, Silveira-Pablos JM, Chong-López A, Alonso DF, Gómez RE, Renault JY, Perrin P, Sigm H, Gold S, Perea-Rodríguez SE, Acevedo-Castro BE, Herrera-Martínez L, López-Saura PA
Publikováno v:
Journal of Cancer Research & Therapy, Vol 1, Iss 6, Pp 163-173 (2013)
CIGB-300 is a pro-apoptotic casein kinase 2 inhibitor peptide with potential anticancer action. An open-label and dose scaling Phase I trial was carried out to investigate the peptide tumor uptake, pharmacokinetics, toxicity, and levels of a CIGB-300
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valenzuela-Silva CM, Tuero-Iglesias AD, García-Iglesias E, González-Díaz O, Del Río-Martín A, Yera Alos IB, Fernández-Montequín JI, López-Saura PA, Valenzuela-Silva, Carmen M, Tuero-Iglesias, Ángela D, García-Iglesias, Elizeth, González-Díaz, Odalys, Del Río-Martín, Amaurys, Yera Alos, Isis Belkis, Fernández-Montequín, José I, López-Saura, Pedro A
Publikováno v:
Diabetes Care; Feb2013, Vol. 36 Issue 2, p210-215, 6p
Autor:
González GP, García IG, González JG, Sánchez LP, Mirabal MV, Marín CC, Ruiz FL, Iglesias EG, de Queralta RL, Toirac RR, Avila MA, Díaz AL, Saura PA, Gavilondo JV, González JP
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Jun2011, Vol. 26 Issue 3, p353-363, 11p
Autor:
Fernández-Montequín JI, Infante-Cristi E, Valenzuela-Silva C, Franco-Pérez N, Savigne-Gutierrez W, Artaza-Sanz H, Morejón-Vega L, González-Benavides C, Eliseo-Musenden O, García-Iglesias E, Berlanga-Acosta J, Silva-Rodríguez R, Betancourt BY, López-Saura PA
Publikováno v:
International Wound Journal; Dec2007, Vol. 4 Issue 4, p333-343, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
García-García I; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba., Hernández-González I; Isotope Center, San José de las Lajas, Mayabeque, Cuba., Díaz-Machado A; National Center for Toxicology, 'Carlos J. Finlay' University Hospital, Havana, Cuba., González-Delgado CA; National Center for Toxicology, 'Carlos J. Finlay' University Hospital, Havana, Cuba., Pérez-Rodríguez S; National Center for Toxicology, 'Carlos J. Finlay' University Hospital, Havana, Cuba., García-Vega Y; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba., Campos-Mojena R; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba., Tuero-Iglesias ÁD; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba., Valenzuela-Silva CM; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba., Cruz-Ramírez A; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba., Martín-Trujillo A; National Center for Toxicology, 'Carlos J. Finlay' University Hospital, Havana, Cuba., Santana-Milián H; Development Direction, Center for Genetic Engineering and Biotechnology, Havana, Cuba., López-Saura PA; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba., Bello-Rivero I; Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Ave. 134 b/23 and 25, Cubanacán, Playa, P.O. Box 6332, Havana, Cuba. iraldo.bello@cigb.edu.cu.
Publikováno v:
BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2016 Dec 07; Vol. 17 (1), pp. 58. Date of Electronic Publication: 2016 Dec 07.
Autor:
Sarduy MR; Gynecological service, Center for Medical-Surgical Research, Havana 11300, Cuba., García I; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Coca MA; Direction for Clinical Research, Clinical Investigation Center, Havana 11300, Cuba., Perera A; Direction for Clinical Research, Clinical Investigation Center, Havana 11300, Cuba., Torres LA; Direction for Clinical Research, Clinical Investigation Center, Havana 11300, Cuba., Valenzuela CM; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Baladrón I; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Solares M; Gyneco-obstetric Hospital 'Ramón González Coro', Havana 10400, Cuba., Reyes V; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Hernández I; Deparment of Development, Isotope Center (CENTIS), Havana 11100, Cuba., Perera Y; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Martínez YM; Gynecological service, Center for Medical-Surgical Research, Havana 11300, Cuba., Molina L; Gynecological service, Center for Medical-Surgical Research, Havana 11300, Cuba., González YM; Gynecological service, Center for Medical-Surgical Research, Havana 11300, Cuba., Ancízar JA; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Prats A; Direction for Clinical Research, Clinical Investigation Center, Havana 11300, Cuba., González L; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Casacó CA; Direction for Clinical Research, Clinical Investigation Center, Havana 11300, Cuba., Acevedo BE; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., López-Saura PA; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba., Alonso DF; Molecular Oncology Laboratory, National University of Quilmes, Buenos Aires, Argentina., Gómez R; ELEA Laboratories, Buenos Aires, Argentina., Perea-Rodríguez SE; CIGB-300 Research and Development Group, Laboratory of Molecular Oncology, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba.
Publikováno v:
British journal of cancer [Br J Cancer] 2015 May 12; Vol. 112 (10), pp. 1636-43. Date of Electronic Publication: 2015 Apr 16.